These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27020720)

  • 1. The effectiveness and safety of amisulpride in Chinese patients with schizophrenia: An 8-week, prospective, open-label, multicenter, single-arm study.
    Liang Y; Cao C; Zhu C; Wang C; Zhang C; Dong F; Yang F; Deng H; Yu J; Tang J; Su L; Xin L; Hong L; Gao M; Tang M; Xie S; Lu S; Liu T; Xu X; Wang X; Li X; Wang X; Li Y; Zhang Y; Chen Z; Yu X
    Asia Pac Psychiatry; 2016 Sep; 8(3):241-4. PubMed ID: 27020720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.
    Kim SW; Shin IS; Kim JM; Lee SH; Lee JH; Yoon BH; Yang SJ; Hwang MY; Yoon JS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1504-9. PubMed ID: 17692448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 6-week, randomized, multicentre, open-label study comparing efficacy and tolerability of amisulpride at a starting dose of 400 mg/day versus 800 mg/day in patients with acute exacerbations of schizophrenia.
    Lee SJ; Lee JH; Jung SW; Koo BH; Choi TY; Lee KH
    Clin Drug Investig; 2012 Nov; 32(11):735-45. PubMed ID: 23018281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Amisulpride Study Group.
    Danion JM; Rein W; Fleurot O
    Am J Psychiatry; 1999 Apr; 156(4):610-6. PubMed ID: 10200742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study.
    Genç Y; Taner E; Candansayar S
    Adv Ther; 2007; 24(1):1-13. PubMed ID: 17526456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment.
    Chen CY; Yeh YW; Kuo SC; Ho PS; Liang CS; Yen CH; Lu RB; Huang SY
    Psychoneuroendocrinology; 2016 Mar; 65():67-75. PubMed ID: 26724569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
    Assion HJ; Reinbold H; Lemanski S; Basilowski M; Juckel G
    Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness and tolerability of amisulpride in patients with schizophrenia: results of a 6-month open study].
    Rzewuska M; Kuczyński W; Luks M
    Psychiatr Pol; 2004; 38(3):453-68. PubMed ID: 15199655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP; Spina E; Murray S; Yang R
    Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amisulpride improves depressive symptoms in acute exacerbations of schizophrenia: comparison with haloperidol and risperidone.
    Peuskens J; Möller HJ; Puech A
    Eur Neuropsychopharmacol; 2002 Aug; 12(4):305-10. PubMed ID: 12126869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness and safety of amisulpride in Chinese patients with schizophrenia who switch from risperidone or olanzapine: a subgroup analysis of the ESCAPE study.
    Liang Y; Yu X
    Neuropsychiatr Dis Treat; 2017; 13():1163-1173. PubMed ID: 28461752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia.
    Mortimer A; Martin S; Lôo H; Peuskens J;
    Int Clin Psychopharmacol; 2004 Mar; 19(2):63-9. PubMed ID: 15076013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients.
    Riedel M; Eich FX; Möller HJ
    Eur Psychiatry; 2009 Apr; 24(3):149-53. PubMed ID: 19070995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rs7968606 polymorphism of ANKS1B is associated with improvement in the PANSS general score of schizophrenia caused by amisulpride.
    Kang SG; Chee IS; Lee K; Lee J
    Hum Psychopharmacol; 2017 Mar; 32(2):. PubMed ID: 28332719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label study.
    Herrera-Estrella M; Apiquian R; Fresan A; Sanchez-Torres I
    BMC Psychiatry; 2005 May; 5():22. PubMed ID: 15869707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group.
    Colonna L; Saleem P; Dondey-Nouvel L; Rein W
    Int Clin Psychopharmacol; 2000 Jan; 15(1):13-22. PubMed ID: 10836281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amisulpride versus risperidone in the treatment of schizophrenic patients: a double-blind pilot study in Taiwan.
    Hwang TJ; Lee SM; Sun HJ; Lin HN; Tsai SJ; Lee YC; Chen YS
    J Formos Med Assoc; 2003 Jan; 102(1):30-6. PubMed ID: 12684609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amisulpride for the treatment of very-late-onset schizophrenia-like psychosis.
    Psarros C; Theleritis CG; Paparrigopoulos TJ; Politis AM; Papadimitriou GN
    Int J Geriatr Psychiatry; 2009 May; 24(5):518-22. PubMed ID: 19072747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus on amisulpride.
    Green B
    Curr Med Res Opin; 2002; 18(3):113-7. PubMed ID: 12094819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical advantages of amisulpride in the treatment of acute schizophrenia.
    Burns T; Bale R
    J Int Med Res; 2001; 29(6):451-66. PubMed ID: 11803729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.